Regeneron COVID-19 treatment enters final stage trials

Regeneron COVID-19 treatment enters final stage trials
The pharmaceutical firm Regeneron on Monday announced it was entering the late stages of its human clinical trials investigating a drug to both treat and prevent COVID-19.